BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15601848)

  • 21. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
    Lee KC; Li J; Cole PA; Wong J; Kraus WL
    Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells.
    Zhang XL; Zhang D; Michel FJ; Blum JL; Simmen FA; Simmen RC
    J Biol Chem; 2003 Jun; 278(24):21474-82. PubMed ID: 12672823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
    Dressing GE; Knutson TP; Schiewer MJ; Daniel AR; Hagan CR; Diep CH; Knudsen KE; Lange CA
    Mol Endocrinol; 2014 Apr; 28(4):442-57. PubMed ID: 24606123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.
    Habran L; Bontems S; Di Valentin E; Sadzot-Delvaux C; Piette J
    J Biol Chem; 2005 Aug; 280(32):29135-43. PubMed ID: 15955820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
    Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
    EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.
    Perkins ND; Felzien LK; Betts JC; Leung K; Beach DH; Nabel GJ
    Science; 1997 Jan; 275(5299):523-7. PubMed ID: 8999795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cyclin E/Cdk2 substrate and Cajal body component p220(NPAT) activates histone transcription through a novel LisH-like domain.
    Wei Y; Jin J; Harper JW
    Mol Cell Biol; 2003 May; 23(10):3669-80. PubMed ID: 12724424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases.
    Redeuilh G; Attia A; Mester J; Sabbah M
    Oncogene; 2002 Aug; 21(37):5773-82. PubMed ID: 12173048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel role for cyclin-dependent kinase 2 in neuregulin-induced acetylcholine receptor epsilon subunit expression in differentiated myotubes.
    Lu G; Seta KA; Millhorn DE
    J Biol Chem; 2005 Jun; 280(23):21731-8. PubMed ID: 15824106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/cdk2 activity.
    Nelson DM; Ye X; Hall C; Santos H; Ma T; Kao GD; Yen TJ; Harper JW; Adams PD
    Mol Cell Biol; 2002 Nov; 22(21):7459-72. PubMed ID: 12370293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation.
    Seo BR; Lee KW; Ha J; Park HJ; Choi JW; Lee KT
    Carcinogenesis; 2004 Aug; 25(8):1387-94. PubMed ID: 15033903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation.
    Contreras A; Hale TK; Stenoien DL; Rosen JM; Mancini MA; Herrera RE
    Mol Cell Biol; 2003 Dec; 23(23):8626-36. PubMed ID: 14612406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator.
    Felzien LK; Farrell S; Betts JC; Mosavin R; Nabel GJ
    Mol Cell Biol; 1999 Jun; 19(6):4241-6. PubMed ID: 10330164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.